Tag Archives | Pharmaceutical systems strengthening

What Gets Defined, Gets Measured: A Definition and Framework for Pharmaceutical Systems Strengthening

A presentation by Helena Walkowiak, Principal Technical Advisor for SIAPS, on December 6 2017.

Read full story · Comments are closed

Now available: “What Gets Defined, Gets Measured” Webinar Recording

On Wednesday, December 6, SIAPS presented its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening.” This webinar defined the terms “pharmaceutical system” and “pharmaceutical systems strengthening” and discussed the identification and piloting of indicators for pharmaceutical systems strengthening and the rationale for undertaking this work. Please find the […]

Read full story · Comments { 0 }

Technical Brief: Transforming Pharmaceutical Services in Ethiopia through Auditable Pharmaceutical Transactions and Services

MSH has implemented pharmaceutical management projects in Ethiopia since 2005, through the Rational Pharmaceutical Management Plus Project and the Strengthening Pharmaceutical Systems (SPS) Program and most recently the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. The SIAPS Program (2011 to 2016) aims to reduce morbidity and mortality, primarily for HIV and AIDS, malaria, and priority conditions in MNCH.

One of the most successful SIAPS initiatives in Ethiopia is implementation of Auditable Pharmaceuticals Transactions and Services (APTS), a package of interventions that addresses accountability and transparency; access to information for decision making; efficient use of medicines budgets and human resources; and quality of pharmacy services—all of which affect the performance of hospitals in the public sector.

Read full story · Comments are closed

To measure progress in “pharmaceutical systems strengthening,” we must first define that term

By Helena Walkowiak, Principal Technical Advisor, SIAPS It’s been called the pharmaceutical sector, a drug supply or management system or the medical products building block. By any name, the part of a health system that deals with ensuring access to essential medicines, vaccines and medical products and their correct use–we call it a pharmaceutical system […]

Read full story · Comments { 0 }

Results and Impact of the Introduction of an Integrated Pharmaceutical Supply System in the Dominican Republic

The objective of this study was to determine, through secondary sources, the impact of SUGEMI on the operational efficiency of the supply system and the availability of general-use medicines in the primary care units (unidades de atención primaria, or UNAP), where SUGEMI is fully implemented. With these ends, interviews were held with 122 personnel responsible for supplies in an equal number of UNAPs and nine URGM coordinators with more than six years’ experience in their respective positions, by means of a structured interview (closed answers), to establish the situation before (2010) and after (2016) implementation of SUGEMI. The sample ensured that the nine Regional Health Services (Servicios Regionales de Salud, or SRSs) were proportionately represented.

To determine the impact of SUGEMI on the availability of medicines for use at the primary care level, the SUGEMI information system database was consulted. This database records the consumption and availability of medicines in the health care facilities, regional warehouses, and central warehouses. On this basis, the availability of 25 “tracer” medicines for primary care use were periodically reported. To establish a relationship between the availability of medicines and particular SUGEMI interventions, other databases were used: the procurement programming exercises allowed the identification of product acquisition prices, and the budgetary allocations were provided by the MSP. The information provided by PROMESE/CAL allowed identification of the number of units acquired and dispatched from 2012 to 2015.

Read full story · Comments are closed

SIAPS Presents on OSPSANTE and OSPSIDA at WHO Francophone Technical Briefing Seminar on Medicine Policy 2016

The World Health Organization Department of Essential Medicines and Health Products invited SIAPS to participate in its annual French Technical Briefing Seminar, held 9-13 May, in Geneva, Switzerland.  The seminar, held every year since 1998, brings together experts working in the pharmaceutical and health sector programs in francophone countries, around current and topical issues related […]

Read full story · Comments { 0 }

Program Review of SIAPS Swaziland

The focus of the review was on assessing SIAPS Swaziland’s role in improving the availability of HIV, TB, and sexual reproductive health (SRH) commodities. The review sought to identify gaps in the technical assistance provided over three years of SIAPS project implementation (October 1, 2011–September 31, 2014). The review findings are intended to Program Review SIAPS Swaziland viii be used to identify the specific areas of focus for USAID/PEPFAR Swaziland.

Read full story · Comments are closed

Defining and Measuring Pharmaceutical Systems Strengthening

The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program convened a consultative meeting of its partners to identify definitions of a pharmaceutical system and pharmaceutical systems strengthening and components to be included in a measurement framework for systems strengthening. The meeting held on September 11-12, 2014, brought together SIAPS core and resource partners, experts from the US Agency for International Development (USAID), the Pan American Health Organization (PAHO) (representing the World Health Organization), and Boston University School of Public Health. The discussions were guided by a background discussion paper prepared by SIAPS staff (page 18) and presentations given at the beginning of each session.

More than 30 participants, who represented 13 different organizations working to improve access and use of pharmaceuticals in low- and middle-income countries, agreed on working definitions of a pharmaceutical system and pharmaceutical systems strengthening.

Read full story · Comments are closed

Defining and Measuring Pharmaceutical Systems Strengthening: Takeaways from the SIAPS Partners Meeting

The achievement of health goals laid out in major USAID initiatives, such as Ending Preventable Child and Maternal Deaths (EPCMD) and creating an AIDS-free Generation (AFG), is largely dependent on health-systems-strengthening (HSS) investments that create long-lasting improvements in health systems performance. Robust measures are essential for gauging the impact of investments in strengthening a health […]

Read full story · Comments { 0 }